ArticleMicromachines2025
Pump-Free Insulin Delivery via an SLA-Printed Hollow Microneedle Patch with an Integrated Self-Sealing Reservoir.
Article in Micromachines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Influence of Light Exposure Time on the Vat Photopolymerization of Methacrylated PVA Microneedles.ACS omega · 2026Article
- The Influence of Mask Modification on Microneedle Strength in Deep X-Ray Lithography.Micromachines · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Hollow microneedle (HMN) systems can deliver insulin with minimal pain, but most rely on external pumps that add bulk, cost, and failure modes. This paper reports the design, fabrication, and mechanical characterisation of a pump-free, refillable HMN patch that integrates a syringe-loadable, self-sealing reservoir and delivers by passive diffusion. A 3 × 4 array of side-orifice conical HMNs with a target height of 1 mm and a bore of 0.8 mm was stereolithography-printed in dental-grade resin and coupled to an elastic-grade resin septum that maintains a leak-free seal after repeated needle puncture. A surface-response design of experiments (DoE) probed wall thickness of 0.10-0.20 mm, post-cure time of 20-60 min, and temperatures of 35-80 °C. The microneedle characteristics include geometric fidelity, insertion into multilayer Parafilm, and axial compression to 150 N. All patches were printed with a hollow channel and side orifices with tips were slightly blunted. Relative to the original design, height undershoot was from -24.5% to -60.5% while base diameters were within -11% to +20%. Parafilm insertion exhibited a peak then force drop at about 0.22 mm displacement with 1.2-1.5 N pierced the first layer. It was found that about 90% of needles penetrated about 381 µm and more than 20% reached 635 µm. Patches withstood 150 N without fracture with strains of 9.7-15.6% and modulus of 8-48 MPa. ANOVA identified wall thickness as a significant factor, with curing temperature not being significant. Contour analysis defined an operating window near a 0.15 mm wall and about 40 min post-cure balancing dimensional fidelity and post-compression height retention. These results define a manufacturable path to compact, pump-free insulin patches with low insertion force and robust mechanics, opening a clinically scalable route to simpler everyday insulin therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.